Axonlab and HAWK Biosystems form strategic partnership to enhance spatial biology solutions across Europe

Axonlab is proud to announce a strategic partnership with HAWK Biosystems, a pioneer in innovative spatial biology technologies. This collaboration signifies a significant step forward in our mission to provide academic and medical researchers across Europe with access to HAWK Biosystems technology.

The partnership between Axonlab and HAWK Biosystems is based on a shared vision of improving healthcare and enhancing the quality of life for patients across Europe by enabling researchers to study protein functional states. Axonlab’s dedication to comprehensive, future-oriented service and building long-term business relations aligns perfectly with HAWK Biosystems’ commitment to innovation and excellence in spatial biology technology.

This collaboration will facilitate the introduction of HAWK Biosystems’ state-of-the-art platforms to a broader market, enabling more researchers and healthcare providers to benefit from their highly sensitive and accurate QF-Pro® technology. QF-Pro® is an advanced bio-imaging platform designed to spatially measure functional proteomic activities in fixed patient samples, such as FFPE tissues, cell lines, and PBMCs. This platform excels in quantifying events like protein-protein interactions and post-translational modifications with exceptional resolution and dynamic range, surpassing existing technologies.

As we embark on this exciting partnership, both HAWK Biosystems and Axonlab are committed to driving forward the development and deployment of innovative spatial biology solutions. Together, we aim to set new standards in the life science and spatial biology industries, ensuring that patients receive the highest quality of care through improved diagnostic and research capabilities.

For more information about our partnership and how it will benefit the life science and spatial biology sector please contact your Life Science Team.